UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

M281, an Anti‐FcRn Antibody: Pharmacodynamics, Pharmacokinetics, and Safety Across the Full Range of IgG Reduction in a First‐in‐Human Study

Clinical pharmacology and therapeutics, 2019-04, Vol.105 (4), p.1031-1039

2019

Volltextzugriff (PDF)

Safety, tolerability, and pharmacology of AB928, a novel dual adenosine receptor antagonist, in a randomized, phase 1 study in healthy volunteers

Investigational new drugs, 2019-08, Vol.37 (4), p.711-721

2019

Volltextzugriff (PDF)

Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial

BMC gastroenterology, 2018-01, Vol.18 (1), p.3-17, Article 3

2018

Volltextzugriff (PDF)

Pharmacodynamics and pharmacokinetics of the novel PAR-1 antagonist vorapaxar (formerly SCH 530348) in healthy subjects

European journal of clinical pharmacology, 2012-03, Vol.68 (3), p.249-258

2012

Volltextzugriff (PDF)

Transient CDK4/6 inhibition protects hematopoietic stem cells from chemotherapy-induced exhaustion

Science translational medicine, 2017-04, Vol.9 (387)

2017

Volltextzugriff (PDF)

Half‐life prolongation of therapeutic proteins by conjugation to ATIII‐binding pentasaccharides: a first‐in‐human study of CarboCarrier® insulin

British journal of clinical pharmacology, 2013-05, Vol.75 (5), p.1221-1230

2013

Volltextzugriff (PDF)

A pharmacokinetics and pharmacodynamics equivalence trial of the proposed pegfilgrastim biosimilar, MYL-1401H, versus reference pegfilgrastim

Journal of cancer research and clinical oncology, 2018-06, Vol.144 (6), p.1087-1095

2018

Volltextzugriff (PDF)

Hyper-Sialylated IgG M254, an Innovative Therapeutic Candidate, Evaluated in Healthy Volunteers and in Patients with Immune Thrombocytopenia Purpura: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics

Blood, 2019-11, Vol.134 (Supplement_1), p.1090-1090

2019

Volltextzugriff (PDF)

Glucose gradient differences in subcutaneous tissue of healthy volunteers assessed with ultraslow microdialysis and a nanolitre glucose sensor

Life sciences (1973), 2002-04, Vol.70 (21), p.2457-2466

2002

Volltextzugriff (PDF)

Slow ultrafiltration for continuous in vivo sampling: application for glucose and lactate in man

Analytica chimica acta, 1999-01, Vol.379 (3), p.327-335

1999

Volltextzugriff (PDF)

A lightweight measuring device for the continuous in vivo monitoring of glucose by means of ultraslow microdialysis in combination with a miniaturised flow-through biosensor

Clinica chimica acta, 2002-02, Vol.316 (1), p.1-10

2002

Volltextzugriff (PDF)

The potential of biosensor technology in clinical monitoring and experimental research

Bio-medical materials and engineering, 2004, Vol.14 (4), p.455

2004

Volltextzugriff (PDF)

An ultrafiltration catheter for monitoring of venous lactate and glucose around myocardial ischemia

Biosensors & bioelectronics, 2001-05, Vol.16 (3), p.159-167

2001

Volltextzugriff (PDF)

First-in-human Phase 1 safety, PK, and PD study of the CDK4/6 inhibitor G1T28

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.2527-2527

2015

Volltextzugriff (PDF)

Evaluation of targeted bone marrow arrest by G1T28, a CDK4/6 inhibitor in clinical development to reduce chemotherapy-induced myelosuppression

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.2529-2529

2015

Volltextzugriff (PDF)

Methodological aspects of glucose monitoring with a slow continuous subcutaneous and intravenous ultrafiltration system in rats

Biosensors & bioelectronics, 1997-01, Vol.12 (9), p.967-976

1997

Volltextzugriff (PDF)

Half‐life prolongation of therapeutic proteins by conjugation to ATIII ‐binding pentasaccharides: a first‐in‐human study of C arbo C arrier ® insulin

British journal of clinical pharmacology, 2013-05, Vol.75 (5), p.1221-1230

2013

Volltextzugriff (PDF)

Pharmacokinetics and tolerability of a novel long-acting glucagon-like peptide-1 analog, CJC-1131, in healthy and diabetic subjects

International journal of clinical pharmacology and therapeutics, 2008-09, Vol.46 (9), p.443-452

2008

Volltextzugriff (PDF)

Drug interaction caused by communication problems. Rhabdomyolysis due to a combination of itraconazole and simvastatin

Nederlands tijdschrift voor geneeskunde, 2010, Vol.154, p.A762

2010

Volltextzugriff (PDF)

Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Encenicline, a Selective α7 Nicotinic Receptor Partial Agonist, in Single Ascending-dose and Bioavailability Studies

Clinical therapeutics, 2015-02, Vol.37 (2), p.311-324

2015

Volltextzugriff (PDF)

Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Encenicline, a Selective [alpha]7Nicotinic Receptor Partial Agonist, in Single Ascending-dose and Bioavailability Studies

Clinical therapeutics, 2015-02, Vol.37 (2), p.311

2015

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(21)

Sprache

Englisch
(20)
Niederländisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(14)
Life Sciences & Biomedicine
(12)
Humans
(11)
Male
(9)
Female
(8)
Adult
(7)
Glucose
(6)
Pharmacology & Pharmacy
(6)
Double-Blind Method
(5)
Middle Aged
(5)
Pharmacokinetics
(5)
Biological And Medical Sciences
(4)
Pharmacodynamics
(4)
Young Adult
(4)
Adolescent
(3)
Biosensing Techniques - Instrumentation
(3)
Biosensor
(3)
Blood Glucose - Analysis
(3)
Chemistry
(3)
Chemistry, Analytical
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

M281, an Anti‐FcRn Antibody: Pharmacodynamics, Pharmacokinetics, and Safety Across the Full Range of IgG Reduction in a First‐in‐Human Study

Safety, tolerability, and pharmacology of AB928, a novel dual adenosine receptor antagonist, in a randomized, phase 1 study in healthy volunteers

Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial

Pharmacodynamics and pharmacokinetics of the novel PAR-1 antagonist vorapaxar (formerly SCH 530348) in healthy subjects

Transient CDK4/6 inhibition protects hematopoietic stem cells from chemotherapy-induced exhaustion

Half‐life prolongation of therapeutic proteins by conjugation to ATIII‐binding pentasaccharides: a first‐in‐human study of CarboCarrier® insulin

A pharmacokinetics and pharmacodynamics equivalence trial of the proposed pegfilgrastim biosimilar, MYL-1401H, versus reference pegfilgrastim

Hyper-Sialylated IgG M254, an Innovative Therapeutic Candidate, Evaluated in Healthy Volunteers and in Patients with Immune Thrombocytopenia Purpura: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics

Glucose gradient differences in subcutaneous tissue of healthy volunteers assessed with ultraslow microdialysis and a nanolitre glucose sensor

Slow ultrafiltration for continuous in vivo sampling: application for glucose and lactate in man

A lightweight measuring device for the continuous in vivo monitoring of glucose by means of ultraslow microdialysis in combination with a miniaturised flow-through biosensor

The potential of biosensor technology in clinical monitoring and experimental research

An ultrafiltration catheter for monitoring of venous lactate and glucose around myocardial ischemia

First-in-human Phase 1 safety, PK, and PD study of the CDK4/6 inhibitor G1T28

Evaluation of targeted bone marrow arrest by G1T28, a CDK4/6 inhibitor in clinical development to reduce chemotherapy-induced myelosuppression

Methodological aspects of glucose monitoring with a slow continuous subcutaneous and intravenous ultrafiltration system in rats

Half‐life prolongation of therapeutic proteins by conjugation to ATIII ‐binding pentasaccharides: a first‐in‐human study of C arbo C arrier ® insulin

Pharmacokinetics and tolerability of a novel long-acting glucagon-like peptide-1 analog, CJC-1131, in healthy and diabetic subjects

Drug interaction caused by communication problems. Rhabdomyolysis due to a combination of itraconazole and simvastatin

Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Encenicline, a Selective α7 Nicotinic Receptor Partial Agonist, in Single Ascending-dose and Bioavailability Studies

Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Encenicline, a Selective [alpha]7Nicotinic Receptor Partial Agonist, in Single Ascending-dose and Bioavailability Studies

Suchergebnisse filtern